Mechanisms of acquired resistance to fibroblast growth factor receptor targeted therapy

Oncogenic activation of the fibroblast growth factor receptor (FGFR) through mutations and fusions of the FGFR gene occur in a variety of different malignancies such as urothelial carcinoma and cholangiocarcinoma. Inhibition of the kinase domain of the FGFR with targeted oral FGFR inhibitors has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, David K., Jenkins, Laura, Weickhardt, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992533/
https://www.ncbi.nlm.nih.gov/pubmed/35582593
http://dx.doi.org/10.20517/cdr.2019.42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992533/
https://www.ncbi.nlm.nih.gov/pubmed/35582593
http://dx.doi.org/10.20517/cdr.2019.42

Ejemplares similares